Last updated 2026-07-20
- Acquired by Bukwang Pharmaceutical, Jan 2023
- Raised $2.3M Seed round led by OrbiMed, Nov 2015
- Raised Series A led by Takeda, Oct 2019
Total raised
$2.3M
Last: Undisclosed Round 2019-11
Stage
Seed
Founded
2015
Headcount
2
HQ
Bnei Brak, Israel
Sector
Health Tech & Life Sciences
About
ProteKt Therapeutics is an Israeli biotech company developing new PKR kinase inhibitor-based therapies for neurodegenerative diseases such as Alzheimer's disease, ALS, Huntington, and Parkinson's. The company's approach involves targeting the PKR enzyme, which is believed to play a role in the development of these diseases. ProteKt Therapeutics has identified small synthetic compounds that can inhibit this enzyme, aiming to bring about cognitive improvements and slow disease progression. The company was founded based on research by Prof. Kobi Rosenblum of the University of Haifa and was part of the FutuRx biotech incubator. In January 2023, ProteKt Therapeutics became a subsidiary of Bukwang Pharmaceutical.
Funding history · 2 rounds · $2.3M total
2019-10
A Round
Undisclosed
★ Takeda★ FutuRx★ OrbiMed★ Fonds de Solidarit FTQ★ Carmel Innovation Fund★ RMGP Biopharma Investment Fund
2015-11
Seed
$2.3M
★ OrbiMed★ Takeda Ventures★ Israel Innovation Authority★ Johnson & Johnson Innovation
Headcount over time
From 6 (2021-01) to 2 (2024-03) · -4 (-67%) · 2 points · source: Finder history + radar grounding
Q&A
- What is Protekt Therapeutics' primary focus?
- Protekt Therapeutics is a biopharmaceutical company focused on identifying and developing a potent and selective oral PKR inhibitor (PKRi) to treat cognitive disorders such as Alzheimer's disease and mild cognitive impairment.
- When was Protekt Therapeutics founded?
- Protekt Therapeutics was founded in December 2014.
- How many employees does Protekt Therapeutics have?
- Protekt Therapeutics has 1-10 employees.
- Who are some of the investors in Protekt Therapeutics' funding rounds?
- Investors in Protekt Therapeutics' funding rounds include OrbiMed and Johnson & Johnson Innovation.
- What is the total amount of funding raised by Protekt Therapeutics?
- Protekt Therapeutics has raised a total of $13,850,000 USD.
- What is the current ownership status of Protekt Therapeutics?
- Protekt Therapeutics is fully owned by Bukwang Pharmaceutical.
- When did Protekt Therapeutics receive its last known funding round?
- Protekt Therapeutics received its last known funding round in November 2019.
- What is the scientific basis for Protekt Therapeutics' approach?
- Protekt Therapeutics' approach is based on technology from Prof. Kobi Rosenblum's lab at Haifa University, focusing on PKR inhibition to modulate processes in Alzheimer's Disease and other neurodegenerative diseases.
Team · 1
Prof. Kobi Rosenblum
Founder · Researcher
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcarePatients
Business model
B2B
Highlights
1 PatentsVerified
Tags
drug-discoverypharmaceuticalsneurologyalzheimers-diseasetherapeuticspatientsamyotrophic-lateral-sclerosis-alsseniorsneurosciencedegenerative-diseasesparkinsonrare-diseasesinflammatory-diseases
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | protektx.com/ |
|---|---|
| facebook.com/Protektx |
Identifiers & details
| Legal name | ProteKt Therapeutics Ltd. |
|---|---|
| Former names | MemoFit |
| Founded | 2015 |
| Employees (exact) | 2 |
Acquisitions & public offerings
Acquired by Bukwang Pharmaceutical 2023-01
Radar intelligence
Patents
| EPO | 1 |
|---|
Web history (Wayback)
| Domain | protektx.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515168573 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2014-12-18 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 0 |
| Registry events | 2 — annual_report (2) |
| Registered address | שלום עליכם 5א רעננה |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-07 | דו~ח שנתי-הסרת דירקטור |
| 2026-06-07 | דו~ח שנתי-הוספת דירקטור |